Patents by Inventor Lizhuang ZHANG

Lizhuang ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11333643
    Abstract: The present invention relates to a quality control method for a Chinese patent drug, and specifically relates to an identification method and a content measurement method for the pediatric compound Endothelium Corneum Gigeriae Galli chewable tablet. Identification is carried out by using specific thin-layer chromatographic identification conditions, and the content is measured by using specific high-performance liquid chromatographic conditions. Accordingly, the specificity and the accuracy are high, chemical components of the product can be fully reflected, the sensitivity is high, the reproducibility is high, the operations are simple, and the change condition of the product quality can be reflected more objectively, comprehensively and sensitively, so that the product quality is controlled on the whole, and comprehensive monitoring of the quality of the Chinese Drug is implemented.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: May 17, 2022
    Assignee: HENAN TALOPH PHARMACEUTICAL CO., LTD.
    Inventors: Zhonghua Guo, Lizhuang Zhang, Weiwei Liu, Muge Qi, Zhiping Zhang, Bingbing Zhang
  • Publication number: 20200182840
    Abstract: The present invention relates to a quality control method for a Chinese patent drug, and specifically relates to an identification method and a content measurement method for the pediatric compound Endothelium Corneum Gigeriae Galli chewable tablet. Identification is carried out by using specific thin-layer chromatographic identification conditions, and the content is measured by using specific high-performance liquid chromatographic conditions. Accordingly, the specificity and the accuracy are high, chemical components of the product can be fully reflected, the sensitivity is high, the reproducibility is high, the operations are simple, and the change condition of the product quality can be reflected more objectively, comprehensively and sensitively, so that the product quality is controlled on the whole, and comprehensive monitoring of the quality of the Chinese Drug is implemented.
    Type: Application
    Filed: August 14, 2018
    Publication date: June 11, 2020
    Inventors: Zhonghua GUO, Lizhuang ZHANG, Weiwei LIU, Muge QI, Zhiping ZHANG, Bingbing ZHANG